Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

NCT00190879 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00190879
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00190879 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2005
Completion date
May 31, 2007
Enrollment
440
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, comorbid social anxiety disorder